Exodus Point Capital Management, LP Veracyte, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Veracyte, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 798,641 shares of VCYT stock, worth $27.2 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
798,641
Previous 147,995
439.64%
Holding current value
$27.2 Million
Previous $3.28 Million
427.65%
% of portfolio
0.12%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding VCYT
# of Institutions
254Shares Held
82.1MCall Options Held
42.3KPut Options Held
18.2K-
Black Rock Inc. New York, NY7.79MShares$265 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.5MShares$255 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6.88MShares$234 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.81MShares$232 Million1.34% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.46MShares$118 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.44B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...